Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,982
archived clinical trials in
Endocrine

Versartis Trial in Children to Assess Long-Acting Growth Hormone
A Long-acting Human Growth Hormone (VRS-317) in Pre-pubertal Children With Growth Hormone Deficiency: A Randomized, Open-label, Multi-center, Phase 1b/2a Study of Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Efficacy After Subcutaneous Administration for 6 Months
Status: Enrolling
Updated:  5/6/2013
mi
from
Chattanooga, TN
Versartis Trial in Children to Assess Long-Acting Growth Hormone
A Long-acting Human Growth Hormone (VRS-317) in Pre-pubertal Children With Growth Hormone Deficiency: A Randomized, Open-label, Multi-center, Phase 1b/2a Study of Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Efficacy After Subcutaneous Administration for 6 Months
Status: Enrolling
Updated: 5/6/2013
Clinical Research Facility
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Versartis Trial in Children to Assess Long-Acting Growth Hormone
A Long-acting Human Growth Hormone (VRS-317) in Pre-pubertal Children With Growth Hormone Deficiency: A Randomized, Open-label, Multi-center, Phase 1b/2a Study of Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Efficacy After Subcutaneous Administration for 6 Months
Status: Enrolling
Updated:  5/6/2013
mi
from
Dallas, TX
Versartis Trial in Children to Assess Long-Acting Growth Hormone
A Long-acting Human Growth Hormone (VRS-317) in Pre-pubertal Children With Growth Hormone Deficiency: A Randomized, Open-label, Multi-center, Phase 1b/2a Study of Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Efficacy After Subcutaneous Administration for 6 Months
Status: Enrolling
Updated: 5/6/2013
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Versartis Trial in Children to Assess Long-Acting Growth Hormone
A Long-acting Human Growth Hormone (VRS-317) in Pre-pubertal Children With Growth Hormone Deficiency: A Randomized, Open-label, Multi-center, Phase 1b/2a Study of Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Efficacy After Subcutaneous Administration for 6 Months
Status: Enrolling
Updated:  5/6/2013
mi
from
Seattle, WA
Versartis Trial in Children to Assess Long-Acting Growth Hormone
A Long-acting Human Growth Hormone (VRS-317) in Pre-pubertal Children With Growth Hormone Deficiency: A Randomized, Open-label, Multi-center, Phase 1b/2a Study of Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Efficacy After Subcutaneous Administration for 6 Months
Status: Enrolling
Updated: 5/6/2013
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials
Effects of Naturally Silicon-Rich Water on Bone Metabolism in Women
Effects of Naturally Occurring Silicon in Drinking Water on Bone Metabolism
Status: Enrolling
Updated:  5/8/2013
mi
from
Los Angeles, CA
Effects of Naturally Silicon-Rich Water on Bone Metabolism in Women
Effects of Naturally Occurring Silicon in Drinking Water on Bone Metabolism
Status: Enrolling
Updated: 5/8/2013
University of California at Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Adult Growth Hormone Deficiency and Cardiovascular Risk
Assessment of Cardiovascular Risk Markers in GH Deficient Patients With Nonsecreting Pituitary Adenomas
Status: Enrolling
Updated:  5/14/2013
mi
from
New York, NY
Adult Growth Hormone Deficiency and Cardiovascular Risk
Assessment of Cardiovascular Risk Markers in GH Deficient Patients With Nonsecreting Pituitary Adenomas
Status: Enrolling
Updated: 5/14/2013
Columbia University College of Physicians and Surgeons
mi
from
New York, NY
Click here to add this to my saved trials
A Study of Adalimumab to Treat Sarcoidosis of the Skin
A Double-Blind, Randomized, Placebo-Controlled Study of Adalimumab in the Treatment of Cutaneous Sarcoidosis
Status: Enrolling
Updated:  5/20/2013
mi
from
Norfolk, VA
A Study of Adalimumab to Treat Sarcoidosis of the Skin
A Double-Blind, Randomized, Placebo-Controlled Study of Adalimumab in the Treatment of Cutaneous Sarcoidosis
Status: Enrolling
Updated: 5/20/2013
Virginia Clinical Research, Inc.
mi
from
Norfolk, VA
Click here to add this to my saved trials
Effects of Aerobic Exercise in Patients With Pre-diabetes
The Effect of Controlled Aerobic Exercise on Endothelial Dysfunction and Vascular Reactivity in Patients With Pre-diabetes: A Crossover Pilot Study
Status: Enrolling
Updated:  5/20/2013
mi
from
Springfield, MA
Effects of Aerobic Exercise in Patients With Pre-diabetes
The Effect of Controlled Aerobic Exercise on Endothelial Dysfunction and Vascular Reactivity in Patients With Pre-diabetes: A Crossover Pilot Study
Status: Enrolling
Updated: 5/20/2013
Baystate Medical Center
mi
from
Springfield, MA
Click here to add this to my saved trials
Adrenocorticotropic Hormone (ACTH) Treatment of Nephrotic Range Proteinuria in Diabetic Nephropathy (NRDN)
"Safety and Efficacy of Acthar Gel on Albuminuria and Urinary Transforming Growth Factor Excretion in Type I or Type II Diabetics Requiring Medical Treatment of Hyperglycemia With Nephrotic Range Proteinuria: A Pilot Study"
Status: Enrolling
Updated:  5/30/2013
mi
from
Chattanooga, TN
Adrenocorticotropic Hormone (ACTH) Treatment of Nephrotic Range Proteinuria in Diabetic Nephropathy (NRDN)
"Safety and Efficacy of Acthar Gel on Albuminuria and Urinary Transforming Growth Factor Excretion in Type I or Type II Diabetics Requiring Medical Treatment of Hyperglycemia With Nephrotic Range Proteinuria: A Pilot Study"
Status: Enrolling
Updated: 5/30/2013
Southeast Renal Research Institute
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Evaluation of Patient Reported Outcome Instruments in Celiac Disease Patients
Clinical Evaluation of Three Celiac Disease-Specific Patient Reported Outcome Instruments in Established and Newly Diagnosed Celiac Disease Patients
Status: Enrolling
Updated:  5/30/2013
mi
from
San Diego, CA
Evaluation of Patient Reported Outcome Instruments in Celiac Disease Patients
Clinical Evaluation of Three Celiac Disease-Specific Patient Reported Outcome Instruments in Established and Newly Diagnosed Celiac Disease Patients
Status: Enrolling
Updated: 5/30/2013
University of California, San Diego
mi
from
San Diego, CA
Click here to add this to my saved trials
Evaluation of Patient Reported Outcome Instruments in Celiac Disease Patients
Clinical Evaluation of Three Celiac Disease-Specific Patient Reported Outcome Instruments in Established and Newly Diagnosed Celiac Disease Patients
Status: Enrolling
Updated:  5/30/2013
mi
from
San Diego, CA
Evaluation of Patient Reported Outcome Instruments in Celiac Disease Patients
Clinical Evaluation of Three Celiac Disease-Specific Patient Reported Outcome Instruments in Established and Newly Diagnosed Celiac Disease Patients
Status: Enrolling
Updated: 5/30/2013
Kaiser Permanente Southern California, Allergy Department
mi
from
San Diego, CA
Click here to add this to my saved trials
Evaluation of Patient Reported Outcome Instruments in Celiac Disease Patients
Clinical Evaluation of Three Celiac Disease-Specific Patient Reported Outcome Instruments in Established and Newly Diagnosed Celiac Disease Patients
Status: Enrolling
Updated:  5/30/2013
mi
from
Denver, CO
Evaluation of Patient Reported Outcome Instruments in Celiac Disease Patients
Clinical Evaluation of Three Celiac Disease-Specific Patient Reported Outcome Instruments in Established and Newly Diagnosed Celiac Disease Patients
Status: Enrolling
Updated: 5/30/2013
University of Colorado, Denver
mi
from
Denver, CO
Click here to add this to my saved trials
Evaluation of Patient Reported Outcome Instruments in Celiac Disease Patients
Clinical Evaluation of Three Celiac Disease-Specific Patient Reported Outcome Instruments in Established and Newly Diagnosed Celiac Disease Patients
Status: Enrolling
Updated:  5/30/2013
mi
from
Chicago, IL
Evaluation of Patient Reported Outcome Instruments in Celiac Disease Patients
Clinical Evaluation of Three Celiac Disease-Specific Patient Reported Outcome Instruments in Established and Newly Diagnosed Celiac Disease Patients
Status: Enrolling
Updated: 5/30/2013
University of Chicago Celiac Disease Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Evaluation of Patient Reported Outcome Instruments in Celiac Disease Patients
Clinical Evaluation of Three Celiac Disease-Specific Patient Reported Outcome Instruments in Established and Newly Diagnosed Celiac Disease Patients
Status: Enrolling
Updated:  5/30/2013
mi
from
Boston, MA
Evaluation of Patient Reported Outcome Instruments in Celiac Disease Patients
Clinical Evaluation of Three Celiac Disease-Specific Patient Reported Outcome Instruments in Established and Newly Diagnosed Celiac Disease Patients
Status: Enrolling
Updated: 5/30/2013
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Evaluation of Patient Reported Outcome Instruments in Celiac Disease Patients
Clinical Evaluation of Three Celiac Disease-Specific Patient Reported Outcome Instruments in Established and Newly Diagnosed Celiac Disease Patients
Status: Enrolling
Updated:  5/30/2013
mi
from
Rochester, MN
Evaluation of Patient Reported Outcome Instruments in Celiac Disease Patients
Clinical Evaluation of Three Celiac Disease-Specific Patient Reported Outcome Instruments in Established and Newly Diagnosed Celiac Disease Patients
Status: Enrolling
Updated: 5/30/2013
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Evaluation of Patient Reported Outcome Instruments in Celiac Disease Patients
Clinical Evaluation of Three Celiac Disease-Specific Patient Reported Outcome Instruments in Established and Newly Diagnosed Celiac Disease Patients
Status: Enrolling
Updated:  5/30/2013
mi
from
New York, NY
Evaluation of Patient Reported Outcome Instruments in Celiac Disease Patients
Clinical Evaluation of Three Celiac Disease-Specific Patient Reported Outcome Instruments in Established and Newly Diagnosed Celiac Disease Patients
Status: Enrolling
Updated: 5/30/2013
Columbia University
mi
from
New York, NY
Click here to add this to my saved trials
Evaluation of Patient Reported Outcome Instruments in Celiac Disease Patients
Clinical Evaluation of Three Celiac Disease-Specific Patient Reported Outcome Instruments in Established and Newly Diagnosed Celiac Disease Patients
Status: Enrolling
Updated:  5/30/2013
mi
from
Cleveland, OH
Evaluation of Patient Reported Outcome Instruments in Celiac Disease Patients
Clinical Evaluation of Three Celiac Disease-Specific Patient Reported Outcome Instruments in Established and Newly Diagnosed Celiac Disease Patients
Status: Enrolling
Updated: 5/30/2013
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Evaluation of Patient Reported Outcome Instruments in Celiac Disease Patients
Clinical Evaluation of Three Celiac Disease-Specific Patient Reported Outcome Instruments in Established and Newly Diagnosed Celiac Disease Patients
Status: Enrolling
Updated:  5/30/2013
mi
from
Philadelphia, PA
Evaluation of Patient Reported Outcome Instruments in Celiac Disease Patients
Clinical Evaluation of Three Celiac Disease-Specific Patient Reported Outcome Instruments in Established and Newly Diagnosed Celiac Disease Patients
Status: Enrolling
Updated: 5/30/2013
Thomas Jefferson University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
An Study to Investigate the Recovery, Excretion, and Pharmacokinetics of 14C-GSK1265744 Administered as a Single Oral Dose and a Study to Describe the Pharmacokinetics of a Supratherapeutic Dose of GSK1265744 in Healthy Adult Subjects
An Open Label, Non-Randomized, Mass Balance Study to Investigate the Recovery, Excretion, and Pharmacokinetics of 14C-GSK1265744 Administered as a Single Oral Dose and a Placebo-Controlled, Randomized Study to Describe the Pharmacokinetics of a Supratherapeutic Dose of GSK1265744 in Healthy Adult Subjects
Status: Enrolling
Updated:  5/30/2013
mi
from
Westwood, KA
An Study to Investigate the Recovery, Excretion, and Pharmacokinetics of 14C-GSK1265744 Administered as a Single Oral Dose and a Study to Describe the Pharmacokinetics of a Supratherapeutic Dose of GSK1265744 in Healthy Adult Subjects
An Open Label, Non-Randomized, Mass Balance Study to Investigate the Recovery, Excretion, and Pharmacokinetics of 14C-GSK1265744 Administered as a Single Oral Dose and a Placebo-Controlled, Randomized Study to Describe the Pharmacokinetics of a Supratherapeutic Dose of GSK1265744 in Healthy Adult Subjects
Status: Enrolling
Updated: 5/30/2013
GSK Investigational Site
mi
from
Westwood, KA
Click here to add this to my saved trials
Assessment of the Effects of Enclomiphene Citrate on Bone Mineral Density in Men With Secondary Hypogonadism
A 12 Month, Single Blind, Placebo Controlled, Phase III Study to Assess the Effects of Enclomiphene Citrate Treatment On Bone Mineral Density in Men With Secondary Hypogonadism
Status: Enrolling
Updated:  6/4/2013
mi
from
Phoenix, AZ
Assessment of the Effects of Enclomiphene Citrate on Bone Mineral Density in Men With Secondary Hypogonadism
A 12 Month, Single Blind, Placebo Controlled, Phase III Study to Assess the Effects of Enclomiphene Citrate Treatment On Bone Mineral Density in Men With Secondary Hypogonadism
Status: Enrolling
Updated: 6/4/2013
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Assessment of the Effects of Enclomiphene Citrate on Bone Mineral Density in Men With Secondary Hypogonadism
A 12 Month, Single Blind, Placebo Controlled, Phase III Study to Assess the Effects of Enclomiphene Citrate Treatment On Bone Mineral Density in Men With Secondary Hypogonadism
Status: Enrolling
Updated:  6/4/2013
mi
from
Santa Clara, CA
Assessment of the Effects of Enclomiphene Citrate on Bone Mineral Density in Men With Secondary Hypogonadism
A 12 Month, Single Blind, Placebo Controlled, Phase III Study to Assess the Effects of Enclomiphene Citrate Treatment On Bone Mineral Density in Men With Secondary Hypogonadism
Status: Enrolling
Updated: 6/4/2013
Clinical Research Facility
mi
from
Santa Clara, CA
Click here to add this to my saved trials
Assessment of the Effects of Enclomiphene Citrate on Bone Mineral Density in Men With Secondary Hypogonadism
A 12 Month, Single Blind, Placebo Controlled, Phase III Study to Assess the Effects of Enclomiphene Citrate Treatment On Bone Mineral Density in Men With Secondary Hypogonadism
Status: Enrolling
Updated:  6/4/2013
mi
from
Daytona Beach, FL
Assessment of the Effects of Enclomiphene Citrate on Bone Mineral Density in Men With Secondary Hypogonadism
A 12 Month, Single Blind, Placebo Controlled, Phase III Study to Assess the Effects of Enclomiphene Citrate Treatment On Bone Mineral Density in Men With Secondary Hypogonadism
Status: Enrolling
Updated: 6/4/2013
Clinical Research Facility
mi
from
Daytona Beach, FL
Click here to add this to my saved trials
Assessment of the Effects of Enclomiphene Citrate on Bone Mineral Density in Men With Secondary Hypogonadism
A 12 Month, Single Blind, Placebo Controlled, Phase III Study to Assess the Effects of Enclomiphene Citrate Treatment On Bone Mineral Density in Men With Secondary Hypogonadism
Status: Enrolling
Updated:  6/4/2013
mi
from
Henderson, NV
Assessment of the Effects of Enclomiphene Citrate on Bone Mineral Density in Men With Secondary Hypogonadism
A 12 Month, Single Blind, Placebo Controlled, Phase III Study to Assess the Effects of Enclomiphene Citrate Treatment On Bone Mineral Density in Men With Secondary Hypogonadism
Status: Enrolling
Updated: 6/4/2013
Clinical Research Facility
mi
from
Henderson, NV
Click here to add this to my saved trials
Assessment of the Effects of Enclomiphene Citrate on Bone Mineral Density in Men With Secondary Hypogonadism
A 12 Month, Single Blind, Placebo Controlled, Phase III Study to Assess the Effects of Enclomiphene Citrate Treatment On Bone Mineral Density in Men With Secondary Hypogonadism
Status: Enrolling
Updated:  6/4/2013
mi
from
Newark, NJ
Assessment of the Effects of Enclomiphene Citrate on Bone Mineral Density in Men With Secondary Hypogonadism
A 12 Month, Single Blind, Placebo Controlled, Phase III Study to Assess the Effects of Enclomiphene Citrate Treatment On Bone Mineral Density in Men With Secondary Hypogonadism
Status: Enrolling
Updated: 6/4/2013
Clinical Research Facility
mi
from
Newark, NJ
Click here to add this to my saved trials
Assessment of the Effects of Enclomiphene Citrate on Bone Mineral Density in Men With Secondary Hypogonadism
A 12 Month, Single Blind, Placebo Controlled, Phase III Study to Assess the Effects of Enclomiphene Citrate Treatment On Bone Mineral Density in Men With Secondary Hypogonadism
Status: Enrolling
Updated:  6/4/2013
mi
from
New York, NY
Assessment of the Effects of Enclomiphene Citrate on Bone Mineral Density in Men With Secondary Hypogonadism
A 12 Month, Single Blind, Placebo Controlled, Phase III Study to Assess the Effects of Enclomiphene Citrate Treatment On Bone Mineral Density in Men With Secondary Hypogonadism
Status: Enrolling
Updated: 6/4/2013
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Assessment of the Effects of Enclomiphene Citrate on Bone Mineral Density in Men With Secondary Hypogonadism
A 12 Month, Single Blind, Placebo Controlled, Phase III Study to Assess the Effects of Enclomiphene Citrate Treatment On Bone Mineral Density in Men With Secondary Hypogonadism
Status: Enrolling
Updated:  6/4/2013
mi
from
Dallas, TX
Assessment of the Effects of Enclomiphene Citrate on Bone Mineral Density in Men With Secondary Hypogonadism
A 12 Month, Single Blind, Placebo Controlled, Phase III Study to Assess the Effects of Enclomiphene Citrate Treatment On Bone Mineral Density in Men With Secondary Hypogonadism
Status: Enrolling
Updated: 6/4/2013
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Assessment of the Effects of Enclomiphene Citrate on Bone Mineral Density in Men With Secondary Hypogonadism
A 12 Month, Single Blind, Placebo Controlled, Phase III Study to Assess the Effects of Enclomiphene Citrate Treatment On Bone Mineral Density in Men With Secondary Hypogonadism
Status: Enrolling
Updated:  6/4/2013
mi
from
Salt Lake City, UT
Assessment of the Effects of Enclomiphene Citrate on Bone Mineral Density in Men With Secondary Hypogonadism
A 12 Month, Single Blind, Placebo Controlled, Phase III Study to Assess the Effects of Enclomiphene Citrate Treatment On Bone Mineral Density in Men With Secondary Hypogonadism
Status: Enrolling
Updated: 6/4/2013
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Safety Study of Abatacept to Treat Refractory Sarcoidosis
Sarcoidosis, Trial of Abatacept in Refractory Disease (STAR). A Prospective Open-Label Trial of Abatacept in Progressive Sarcoidosis
Status: Enrolling
Updated:  6/10/2013
mi
from
Chicago, IL
Safety Study of Abatacept to Treat Refractory Sarcoidosis
Sarcoidosis, Trial of Abatacept in Refractory Disease (STAR). A Prospective Open-Label Trial of Abatacept in Progressive Sarcoidosis
Status: Enrolling
Updated: 6/10/2013
University of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Effects of Standing on Glycemia in Prediabetic Adults
Acute Effects of Standing on Glycemia in Prediabetic Adults: A Pilot Study
Status: Enrolling
Updated:  6/21/2013
mi
from
St. Paul, MN
Effects of Standing on Glycemia in Prediabetic Adults
Acute Effects of Standing on Glycemia in Prediabetic Adults: A Pilot Study
Status: Enrolling
Updated: 6/21/2013
Department of Human Services
mi
from
St. Paul, MN
Click here to add this to my saved trials
Effects of TNF-alpha Antagonism (Etanercept) in Patients With the Metabolic Syndrome and Psoriasis
Effects of TNF-alpha Antagonism (Etanercept) in Patients With the Metabolic Syndrome and Psoriasis
Status: Enrolling
Updated:  6/25/2013
mi
from
Boston, MA
Effects of TNF-alpha Antagonism (Etanercept) in Patients With the Metabolic Syndrome and Psoriasis
Effects of TNF-alpha Antagonism (Etanercept) in Patients With the Metabolic Syndrome and Psoriasis
Status: Enrolling
Updated: 6/25/2013
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Insulin Resistance in Non-alcoholic Fatty Liver Disease
Insulin Resistance in Non-alcoholic Fatty Liver Disease (Protocol Drug Change From Project CDA-2-044-08S)
Status: Enrolling
Updated:  7/8/2013
mi
from
Seattle, WA
Insulin Resistance in Non-alcoholic Fatty Liver Disease
Insulin Resistance in Non-alcoholic Fatty Liver Disease (Protocol Drug Change From Project CDA-2-044-08S)
Status: Enrolling
Updated: 7/8/2013
VA Puget Sound Health Care System, Seattle
mi
from
Seattle, WA
Click here to add this to my saved trials
Does Class of Dietary Fat Affect Insulin Resistance?
Insulin Resistance and Dietary Fat
Status: Enrolling
Updated:  7/11/2013
mi
from
Rochester, MN
Does Class of Dietary Fat Affect Insulin Resistance?
Insulin Resistance and Dietary Fat
Status: Enrolling
Updated: 7/11/2013
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Calcium Homeostasis in Acromegaly: Effect of Surgical/Medical Treatment and Comparison With Nonfunctioning Pituitary Tumors
Calcium Homeostasis in Acromegaly: Effect of Surgical/Medical Treatment and Comparison With Nonfunctioning Pituitary Tumors.
Status: Enrolling
Updated:  7/18/2013
mi
from
Atlanta, GA
Calcium Homeostasis in Acromegaly: Effect of Surgical/Medical Treatment and Comparison With Nonfunctioning Pituitary Tumors
Calcium Homeostasis in Acromegaly: Effect of Surgical/Medical Treatment and Comparison With Nonfunctioning Pituitary Tumors.
Status: Enrolling
Updated: 7/18/2013
The Emory Clinic
mi
from
Atlanta, GA
Click here to add this to my saved trials
Calcium Homeostasis in Acromegaly: Effect of Surgical/Medical Treatment and Comparison With Nonfunctioning Pituitary Tumors
Calcium Homeostasis in Acromegaly: Effect of Surgical/Medical Treatment and Comparison With Nonfunctioning Pituitary Tumors.
Status: Enrolling
Updated:  7/18/2013
mi
from
Atlanta, GA
Calcium Homeostasis in Acromegaly: Effect of Surgical/Medical Treatment and Comparison With Nonfunctioning Pituitary Tumors
Calcium Homeostasis in Acromegaly: Effect of Surgical/Medical Treatment and Comparison With Nonfunctioning Pituitary Tumors.
Status: Enrolling
Updated: 7/18/2013
Emory University Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
Moderate Intensity Exercise and Phenylketonuria
The Effects of an Acute Bout of Moderate Intensity Exercise on Plasma Amino Acids in Subjects With Phenylketonuria
Status: Enrolling
Updated:  7/19/2013
mi
from
Portland, OR
Moderate Intensity Exercise and Phenylketonuria
The Effects of an Acute Bout of Moderate Intensity Exercise on Plasma Amino Acids in Subjects With Phenylketonuria
Status: Enrolling
Updated: 7/19/2013
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Examining the Effects of Antipsychotic Medications on Insulin Sensitivity
Acute Impact of Antipsychotics on Insulin Sensitivity: A Novel Human Model
Status: Enrolling
Updated:  8/6/2013
mi
from
San Diego, CA
Examining the Effects of Antipsychotic Medications on Insulin Sensitivity
Acute Impact of Antipsychotics on Insulin Sensitivity: A Novel Human Model
Status: Enrolling
Updated: 8/6/2013
VA San Diego Healthcare System
mi
from
San Diego, CA
Click here to add this to my saved trials
Ziprasidone for Improving Insulin Sensitivity in People With Schizophrenia Who Are at Risk for Diabetes
The Metabolic Syndrome in Patients With Schizophrenia
Status: Enrolling
Updated:  8/6/2013
mi
from
San Diego, CA
Ziprasidone for Improving Insulin Sensitivity in People With Schizophrenia Who Are at Risk for Diabetes
The Metabolic Syndrome in Patients With Schizophrenia
Status: Enrolling
Updated: 8/6/2013
VA San Diego Healthcare System
mi
from
San Diego, CA
Click here to add this to my saved trials
Feasibility Study Assessing the Ability of an Insulin Pump-controlling Algorithm to Minimize Hypoglycemia
Feasibility Study Assessing the Ability of an Insulin Pump-controlling Algorithm to Minimize Hypoglycemia in Patients With Type 1 Diabetes in a Clinical Research Setting
Status: Enrolling
Updated:  8/8/2013
mi
from
Santa Barbara, CA
Feasibility Study Assessing the Ability of an Insulin Pump-controlling Algorithm to Minimize Hypoglycemia
Feasibility Study Assessing the Ability of an Insulin Pump-controlling Algorithm to Minimize Hypoglycemia in Patients With Type 1 Diabetes in a Clinical Research Setting
Status: Enrolling
Updated: 8/8/2013
Samsum Diabetes Reserach Inst.
mi
from
Santa Barbara, CA
Click here to add this to my saved trials
Regulating Efficacy and Wellness in Diabetes
Social Cognitive and Neuropsychological Influences on Physical Activity Behavior in Type II Diabetes
Status: Enrolling
Updated:  8/9/2013
mi
from
Urbana, IL
Regulating Efficacy and Wellness in Diabetes
Social Cognitive and Neuropsychological Influences on Physical Activity Behavior in Type II Diabetes
Status: Enrolling
Updated: 8/9/2013
University of Illinois at Urbana-Champaign
mi
from
Urbana, IL
Click here to add this to my saved trials
Evaluation of the Pharmacokinetics and Safety of Androxal in Male Subjects With Impaired Hepatic Function
An Open Label Study to Evaluate the Pharmacokinetics and Safety Profile of Androxal in Male Subjects With Impaired Hepatic Function
Status: Enrolling
Updated:  8/14/2013
mi
from
Miami, FL
Evaluation of the Pharmacokinetics and Safety of Androxal in Male Subjects With Impaired Hepatic Function
An Open Label Study to Evaluate the Pharmacokinetics and Safety Profile of Androxal in Male Subjects With Impaired Hepatic Function
Status: Enrolling
Updated: 8/14/2013
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
Dairy Fat as a Mediator of Vitamin E Adequacy in Individuals With Metabolic Syndrome
Dairy Fat as a Mediator of Vitamin E Adequacy in Individuals With Metabolic Syndrome
Status: Enrolling
Updated:  8/27/2013
mi
from
Columbus, OH
Dairy Fat as a Mediator of Vitamin E Adequacy in Individuals With Metabolic Syndrome
Dairy Fat as a Mediator of Vitamin E Adequacy in Individuals With Metabolic Syndrome
Status: Enrolling
Updated: 8/27/2013
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Effect of Exercise on Insulin Resistance
Effect of Exercise on Insulin Resistance
Status: Enrolling
Updated:  9/10/2013
mi
from
Renton, WA
Effect of Exercise on Insulin Resistance
Effect of Exercise on Insulin Resistance
Status: Enrolling
Updated: 9/10/2013
Rainier Clinical Research Center Inc.
mi
from
Renton, WA
Click here to add this to my saved trials
mi
from
Beltsville, MD
Beltsville Human Nutrition Research Center
mi
from
Beltsville, MD
Click here to add this to my saved trials
A Study of Ejaculatory Dysfunction in Men With Low Testosterone Levels
A Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study to Explore the Impact of Testosterone Solution 2% on Symptoms of Ejaculatory Dysfunction in Men With Testosterone Deficiency
Status: Enrolling
Updated:  9/13/2013
mi
from
Los Angeles, CA
A Study of Ejaculatory Dysfunction in Men With Low Testosterone Levels
A Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study to Explore the Impact of Testosterone Solution 2% on Symptoms of Ejaculatory Dysfunction in Men With Testosterone Deficiency
Status: Enrolling
Updated: 9/13/2013
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Study of Ejaculatory Dysfunction in Men With Low Testosterone Levels
A Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study to Explore the Impact of Testosterone Solution 2% on Symptoms of Ejaculatory Dysfunction in Men With Testosterone Deficiency
Status: Enrolling
Updated:  9/13/2013
mi
from
Alexandria, LA
A Study of Ejaculatory Dysfunction in Men With Low Testosterone Levels
A Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study to Explore the Impact of Testosterone Solution 2% on Symptoms of Ejaculatory Dysfunction in Men With Testosterone Deficiency
Status: Enrolling
Updated: 9/13/2013
Clinical Research Facility
mi
from
Alexandria, LA
Click here to add this to my saved trials
A Study of Ejaculatory Dysfunction in Men With Low Testosterone Levels
A Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study to Explore the Impact of Testosterone Solution 2% on Symptoms of Ejaculatory Dysfunction in Men With Testosterone Deficiency
Status: Enrolling
Updated:  9/13/2013
mi
from
Boston, MA
A Study of Ejaculatory Dysfunction in Men With Low Testosterone Levels
A Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study to Explore the Impact of Testosterone Solution 2% on Symptoms of Ejaculatory Dysfunction in Men With Testosterone Deficiency
Status: Enrolling
Updated: 9/13/2013
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
A Study of Ejaculatory Dysfunction in Men With Low Testosterone Levels
A Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study to Explore the Impact of Testosterone Solution 2% on Symptoms of Ejaculatory Dysfunction in Men With Testosterone Deficiency
Status: Enrolling
Updated:  9/13/2013
mi
from
Brooklyn, NY
A Study of Ejaculatory Dysfunction in Men With Low Testosterone Levels
A Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study to Explore the Impact of Testosterone Solution 2% on Symptoms of Ejaculatory Dysfunction in Men With Testosterone Deficiency
Status: Enrolling
Updated: 9/13/2013
Clinical Research Facility
mi
from
Brooklyn, NY
Click here to add this to my saved trials
A Trial to Investigate the Bioequivalence of Norditropin® (Somatropin) Versus Genotropin® (Somatropin) in Healthy Adult Subjects
A Trial to Investigate the Bioequivalence of Norditropin® (Somatropin) Versus Genotropin® (Somatropin) in Healthy Adult Subjects
Status: Enrolling
Updated:  9/17/2013
mi
from
Topeka, KA
A Trial to Investigate the Bioequivalence of Norditropin® (Somatropin) Versus Genotropin® (Somatropin) in Healthy Adult Subjects
A Trial to Investigate the Bioequivalence of Norditropin® (Somatropin) Versus Genotropin® (Somatropin) in Healthy Adult Subjects
Status: Enrolling
Updated: 9/17/2013
Novo Nordisk Clinical Trial Call Center
mi
from
Topeka, KA
Click here to add this to my saved trials
Effects of Thyroid Hormone Enzyme Blocking on Hypothyroidism
Effects of Pharmacologic Block of Type-1 Deiodinase on Thyroid Hormone Action and on the Circulating Levels of T3 in Hypothyroid Patients
Status: Enrolling
Updated:  10/5/2013
mi
from
Bethesda, MD
Effects of Thyroid Hormone Enzyme Blocking on Hypothyroidism
Effects of Pharmacologic Block of Type-1 Deiodinase on Thyroid Hormone Action and on the Circulating Levels of T3 in Hypothyroid Patients
Status: Enrolling
Updated: 10/5/2013
National Institutes of Health Clinical Center
mi
from
Bethesda, MD
Click here to add this to my saved trials
Pegvisomant With Glucagon Test to Assess for Adult Growth Hormone Deficiency
Effects of Pegvisomant-Priming With the Glucagon Stimulation Test in Assessing GH and Cortisol Reserve in Adults: a Randomized Proof-of-Concept Pilot Study
Status: Enrolling
Updated:  10/23/2013
mi
from
Portland, OR
Pegvisomant With Glucagon Test to Assess for Adult Growth Hormone Deficiency
Effects of Pegvisomant-Priming With the Glucagon Stimulation Test in Assessing GH and Cortisol Reserve in Adults: a Randomized Proof-of-Concept Pilot Study
Status: Enrolling
Updated: 10/23/2013
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Triple Blockade of the Renin Angiotensin Aldosterone System in Diabetic (Type 1&2) Proteinuric Patients
Study of Triple Blockade of the Renin Angiotensin Aldosterone System (RAAS) in Diabetic (Type 1&2) Proteinuric Patients With (ACE-, ARB, DRI)
Status: Enrolling
Updated:  10/24/2013
mi
from
Chicago, IL
Triple Blockade of the Renin Angiotensin Aldosterone System in Diabetic (Type 1&2) Proteinuric Patients
Study of Triple Blockade of the Renin Angiotensin Aldosterone System (RAAS) in Diabetic (Type 1&2) Proteinuric Patients With (ACE-, ARB, DRI)
Status: Enrolling
Updated: 10/24/2013
John H Stroger Hospital of Cook County
mi
from
Chicago, IL
Click here to add this to my saved trials